Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating and Adjusts Price Target for Phreesia NYSE PHR

Elaine Mendonca by Elaine Mendonca
January 18, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On January 18, 2024, Ryan MacDonald, an analyst at Needham, expressed his optimistic view on Phreesia (NYSE: PHR) by reiterating a Buy rating and maintaining a price target of $29. This reaffirmation of confidence in the company’s stock indicates the potential for upward movement. Although the price target has been adjusted from $40 to $29, the Buy recommendation showcases MacDonald’s belief in Phreesia’s future performance.

PHR Stock Performance Declines on January 18, 2024: A Detailed Analysis

PHR, a publicly traded company, experienced a decline in its stock performance on January 18, 2024. According to data sourced from CNN Money, the stock closed at $24.03, marking a decrease of $0.68 or 2.75% from the previous market close. Additionally, in after-hours trading, the stock dropped a further $0.20.

PHR Stock Performance on January 18, 2024: Mixed Revenue Growth and Net Income Decline

PHR Stock Performance on January 18, 2024: A Mixed Bag of Revenue Growth and Net Income Decline

On January 18, 2024, PHR stock experienced a mixed performance as the company’s revenue showed promising growth, while its net income declined.

Total revenue for PHR stood at $280.91 million for the past year, representing a substantial increase of 31.74% compared to the previous year. Additionally, the company’s total revenue also increased by 6.74% since the last quarter.

However, the picture is not entirely rosy, as PHR’s net income witnessed a decline. Over the past year, the company reported a net income of -$176.15 million, reflecting a decrease of 49.07% compared to the previous year. On a positive note, the net income increased by 13.13% since the last quarter.

The earnings per share (EPS) is another crucial metric to assess a company’s financial performance. PHR reported an EPS of -$3.36 for the past year, which is a decrease of 41.82% compared to the previous year. However, there was a slight improvement in the EPS since the last quarter, with a 15.42% increase.

Overall, the stock performance of PHR on January 18, 2024, showcased a mix of positive and negative indicators. While the company experienced significant revenue growth over the past year and quarter, the net income and EPS declined on a yearly basis. However, there was a slight improvement in net income and EPS since the last quarter, which may indicate that PHR is taking steps to address its profitability challenges.

Investors should carefully analyze these financial metrics and consider other factors, such as market conditions and industry trends, before making any investment decisions related to PHR stock. It is essential to assess the company’s long-term strategy, competitive positioning, and ability to adapt to changing market dynamics to make informed investment choices.

Tags: PHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Market Capitalization

Introducing Club92 Dollar Generals Exclusive Home Fragrance Collection

Technology Robotics Trading online

Analysts Provide Mixed Ratings and Price Targets for Impinj NASDAQPI

CTVA stock news

Mixed Analyst Sentiments and Price Targets for Adobe NASDAQ ADBE

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com